SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001437749-22-018465
Filing Date
2022-08-02
Accepted
2022-08-02 16:58:59
Documents
2
Period of Report
2022-07-29

Document Format Files

Seq Description Document Type Size
1 FORM 3 rdgdoc.html 3  
1 FORM 3 rdgdoc.xml 3 1441
2 pbyi20220727.htm EX-24 6661
  Complete submission text file 0001437749-22-018465.txt   9573
Mailing Address 10880 WILSHIRE BLVD. SUITE 2150 LOS ANGELES CA 90024
Business Address 10880 WILSHIRE BLVD. SUITE 2150 LOS ANGELES CA 90024 (424) 248-6500
PUMA BIOTECHNOLOGY, INC. (Issuer) CIK: 0001401667 (see all company filings)

IRS No.: 770683487 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 700 BALTIC CIRCLE, SUITE 716 REDWOOD CITY CA 94065
Business Address
Cesano Alessandra (Reporting) CIK: 0001827015 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35703 | Film No.: 221129578